Gravar-mail: One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133(+) Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction